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Abstract
L2-Glycoprotein I (L2GP1), a 50 kDa serum glycoprotein, binds anionic phospholipids and plays a role in
phosphatidylserine (PS)-dependent coagulation and apoptotic processes. To characterize the molecular consequences that
occur to target membranes upon binding of L2GP1, the interaction between L2GP1 and PS-containing vesicles was
investigated by fluorescent spectroscopy. Membranes containing pyrene-labeled lipid showed that binding of L2GP1 induced
a decrease in excimer/monomor ratios (E/M) of the target membrane. Although these membrane alterations occurred in
isotonic buffer, the effects were greater in low ionic strength buffer and were coincident to membrane precipitation. In
contrast, increases in membrane polarization were only seen in low ionic strength buffer. Analysis of L2GP1 binding kinetics
by resonance energy transfer between fluorescein-labeled L2GP1 and rhodamine-containing PS vesicles revealed a two-
component process: (1) a primary and rapid binding via the C-terminus that occurred 6 2 s in both isotonic and low ionic
strength buffers, and (2) a sequential binding of the N-terminus that was V100-fold slower in low ionic strength solution.
Taken together, these data suggest that L2GP1 alters the fluidity and membrane polarization of its target membrane, which in
low ionic strength buffer is of sufficient magnitude to induce precipitation. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
L2-Glycoprotein I (L2GP1), a 50 kDa glycoprotein,
is the major lipid binding protein in plasma and
plays a role in autoimmunity [1^3], coagulation [4]
and the clearance of apoptotic and senescent cells [5^
8]. It is composed of 326 amino acids and is a mem-
ber of the short consensus repeat (SCR) superfamily
containing four typical repeating domains and an
aberrant ¢fth domain constructed onto a SCR-like
core at the C-terminus [9^11]. While both domains I
and V exhibit lipid binding properties, the ¢fth do-
main is the principal lipid binding domain [12^14].
Lipid binding in domain V occurs through a series of
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(7-nitrobenz-2-oxa-1,3 diazo-4-yl) 1,2 diacyl-L-K-phosphatidyleth-
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diacyl-L-K-phosphatidylethanolamine; DPH, 1,6-diphenyl-1,3,5-
hexatriene; FITC, £uorescein-5-isothiocyanate; Tris^EDTA, 10
mM Tris, 0.1 mM EDTA, pH 7.0
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positively-charged lysine residues [15,16] that likely
results in the insertion of a partially hydrophobic
loop into the lipid bilayer [17]. From its crystal struc-
ture, Bouma et al. [18] suggested that domains I
through IV remain in solution leaving the N-termi-
nus available for other membrane interactions. Con-
ceivably, this could occur through other negatively
charged lipids or speci¢c cell surface receptors.
Various studies have indicated that the binding of
L2GP1 with target membranes bearing negatively-
charged lipids induce agglutination and precipitation
[19,20]. However, the mechanism responsible for the
precipitation of membranes upon binding of L2GP1
is unknown. Conceivably, precipitation could be due
to simple aggregation as a result of bivalent (or mul-
tivalent) protein^lipid interactions, or because of di-
rect alterations in the properties of the target mem-
brane. To characterize the interaction between
L2GP1 and phospholipid membranes, a series of £uo-
rescent measurements, light-scattering intensity mea-
surements and precipitation experiments were carried
out. Our results suggest that precipitation of mem-
branes with L2GP1 involves at least two distinct
binding interactions. Critical primary binding in-
duces local membrane changes, which in turn, can
propagate to sequential secondary interactions that
result in global membrane alterations leading to pre-
cipitation.
2. Materials and methods
2.1. Materials and routine procedures
Dioleoylphosphatidylcholine (PC), bovine brain
PS, N-Rho-PE and N-NBD-PE were from Avanti
Polar Lipids (Alabaster, AL). Pyr-PC and DPH
were purchased from Molecular Probes (Eugene,
OR). Lipid concentrations were determined by phos-
phate assay and tested for purity by thin layer chro-
matography in CHCl3/MEOH/H2O (65:25:4). Fluo-
rescence was measured with a Perkin^Elmer LS-50B
spectrophotometer. Small unilamellar vesicles (SUV)
were prepared by drying lipids under N2 and sonicat-
ing in Tris^EDTA (10 mM Tris/0.1 mM EDTA; pH
7.0) at 4‡C. Large vesicles and titanium fragments
were removed by centrifugation at 15 000Ug for
15 min. G274^C288 (GDKVSFFCKNKEKKC), a
peptide corresponding to the domain V lipid binding
site of L2GP1, was synthesized by the synthetic anti-
gen core facility at M.D. Anderson Cancer Center,
Houston, TX. L2GP1 antibodies were produced in
rabbits as previously described [6].
2.2. Puri¢cation of L2GP1
L2GP1 was puri¢ed from pooled human plasma
(Gulf Coast Regional Blood Center, Houston, TX)
by perchloric acid (2.2% v/v) precipitation. The acid-
soluble fraction was further puri¢ed by ion exchange
chromatography on DEAE^cellulose and heparin-af-
¢nity chromatography [19^21]. Protein concentration
was determined with the Pierce bicinchoninic acid
assay [22]. Sodium dodecyl sulfate^polyacrylamide
gel electrophoresis (SDS^PAGE) analysis revealed a
single silver stained band at 50 kDa [6]. Western
blotting con¢rmed the band to be L2GP1 and lipo-
blotting revealed that the protein speci¢cally bound
PS-containing vesicles [23].
2.3. Fluorescent labeling of L2GP1
Human L2GP1 contains a free sulfhydryl at CYS
102 and/or CYS 169 [9,11] located in domains II and
III, respectively. These sites were labeled with FITC^
maleimide. Brie£y, 20 nmol of L2GP1 in Tris^EDTA
were labeled with 2 Wmol of FITC^maleimide
(100 mM stock in DMSO) for 1 h at 20‡C. Un-
reacted reagent was removed by overnight dialysis
against Tris^EDTA followed by column chromatog-
raphy on Biogel P-6 equilibrated in the same bu¡er.
The FITC/protein ratio was estimated to be V2.1:1
from the absorbance at 493 and 280 nm [24].
2.4. Fluorescence measurements
Preliminary analysis of the kinetics of interaction
between L2GP1 and vesicles using the spectroscopic
methods described below indicated no changes in
£uorescence beyond V4 min. For this reason all
£uorescent analysis were measured after 5 min of
incubation.
2.4.1. Pyrene-labeled PC
The in£uence of L2GP1 on membranes was moni-
tored by the ratio of the £uorescence of the excimer
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(E) and monomer (M) of Pyr-PC at 477 and 399 nm,
respectively (Vex 345 nm) [25,26]. Brie£y, PC/PS
vesicles (4 WM) labeled with Pyr-PC (10 mol%) in
Tris^EDTA with or without NaCl (150 mM) were
incubated with increasing concentrations of L2GP1.
The percent change in E/M was calculated as de-
scribed by Junker and Creutz [27]:
E=Mfinal3E=Minitial=E=MinitialU100 1
where (E/M)initial was the £uorescence ratio of
vesicles alone and (E/M)final was the £uorescence ra-
tio after the addition of L2GP1.
2.4.2. DPH Polarization
DPH was utilized to measure membrane polariza-
tion (P). Brie£y, vesicles (4 WM) containing increas-
ing concentrations of PS in PC were prepared in
Tris^EDTA with or without NaCl (150 mM). The
vesicles were then incubated with DPH (1 WM) at
30‡C for 1 h. P was monitored (Vex 356 nm, Vem
430 nm) at 25‡C with increasing concentrations of
L2GP1. P was calculated by the following equation
[28,29]:
P  Ihh3GIhv=Ihh  GIhv 2
where Ihv and Ihh are the £uorescent intensities when
the polarizers are perpendicular and parallel, respec-
tively, and G is the grating factor.
2.4.3. Resonance energy transfer (RET)
RET experiments were carried out to monitor
L2GP1-dependent vesicle^vesicle interactions and
protein^vesicle interactions. Vesicle^vesicle interac-
tions were determined by incubating equimolar con-
centrations of donor and acceptor vesicles for 5 min
at 20‡C. Donor vesicles consisted of PC/PS vesicles
containing N-NBD-PE (1 mol%); acceptor vesicles
consisted of PC or PC/PS vesicles labeled with N-
Rho-PE (2 mol%) [30]. Emission spectra were re-
corded between 500 and 600 nm (Vex 450 nm) before
and after the addition of L2GP1. RET was measured
as a function of the decrease in NBD emission inten-
sity at 528 nm. Vesicles fused with Ca2 (5 mM)
served as positive controls [31^33]. The interaction
of L2GP1 with vesicles was monitored as described
above except that FITC-labeled L2GP1 and N-Rho-
PE labeled PC/PS vesicles were used as the £uores-
cent donor and acceptor, respectively.
2.5. Precipitation of vesicles with L2GP1
L2GP1-dependent precipitation curves were gener-
ated using vesicles labeled with N-NBD-PE and/or
N-Rho-PE. Brie£y, vesicles were incubated with
L2GP1 for 1 h at 20‡C. Aliquots were removed be-
fore and after centrifugation (15 000Ug for 15 min).
The £uorescence was measured at their respective
wavelengths and the fraction of precipitated vesicles
was calculated from the di¡erence in intensities of
the supernatant before and after centrifugation.
2.6. Light-scattering measurements
The association of L2GP1 to PS-containing vesicles
was measured by light-scattering intensity as de-
scribed by Nelsestuen and Lim [34]. Brie£y, 90‡
light-scattering intensity was monitored at 320 nm
in Tris^EDTA with or without NaCl (150 mM).
L2GP1 was added to the cuvette and light-scattering
intensity of the protein^vesicle complex (I2) was com-
pared to the light-scattering intensity of the vesicles
alone (I1). M2/M1 was calculated according to the
following equation as described previously [34]:
I2=I1  M2=M12 3
where M2 is the relative molecular mass of the com-
plex and M1 is the relative molecular mass of vesicles
alone. I2 and I1 were corrected for dilution and light-
scattering intensity of the free protein. Positive con-
trols for the induction of large aggregates were gen-
erated from vesicle/L2GP1 complexes that were
treated with L2GP1 antibodies (20 Wg/ml) for 10
min at 20‡C.
2.7. Statistical analysis
Results are expressed as mean þ S.E.M. for at least
four separate experiments performed with di¡erent
reagents.
3. Results
3.1. L2GP1-Induced precipitation of PS vesicles
To determine the propensity of L2GP1 to precip-
itate PS-containing membranes, N-Rho-PE-labeled
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vesicles were incubated with increasing concentra-
tions of L2GP1 for 1 h at 20‡C in the presence and
absence of 150 mM NaCl. The data presented in Fig.
1 shows that maximum precipitation occurred at
V200 nM L2GP1 in the absence of salt. The vesicles
did not precipitate when the incubation mixture con-
tained 150 mM NaCl or when the vesicles were in-
cubated with G274^C288, a peptide corresponding to
the L2GP1 lipid-binding site. Pure PC vesicles did not
precipitate (not shown).
3.2. L2GP1 induces decreased E/M ratio and increased
membrane polarization
The addition of L2GP1 to PS containing vesicles
resulted in a decrease in the excimer to monomer
ratio (E/M), suggesting a decrease in the lateral mo-
bility as well as a change in the local concentration
of the £uorophore in the membrane [25,26] (Fig. 2).
The changes in E/M were signi¢cantly greater when
the experiment was carried out in the absence of salt.
Consistent with the data obtained in the precipita-
tion experiment described above, alterations in E/M
with G274^C288 were essentially identical to those ob-
tained with the intact protein in the presence of 150
mM NaCl. The decrease in E/M could be due to
alterations in the lateral dispersion of the probe or
to a decrease in the collisional frequency as a result
of enhanced membrane rigidity. To distinguish be-
tween these possibilities, global changes in membrane
polarization as a function of both the concentration
of PS and L2GP1 were measured in DPH labeled
vesicles. As can be seen in Fig. 3A, P increased as
a function of both the concentration of L2GP1 and
the fraction of PS in the membrane. Unlike the re-
sults obtained with pyrene-labeled vesicles, however,
the inclusion of 150 mM NaCl in the incubation
medium resulted in V60% reduction in L2GP1-de-
pendent changes in membrane polarization (Fig. 3B)
that was coincident to the inhibition of vesicle pre-
cipitation (Fig. 1).
3.3. In£uence of L2GP1 on vesicle size
L2GP1-Dependent precipitation of vesicles results
in leakage of vesicle contents [35]. This raises the
possibility that precipitation could be due to the for-
mation of large fused vesicles. To determine whether
L2GP1 induced fusion, pyrene-labeled membranes
were incubated with a 5-fold excess of unlabeled
Fig. 1. Precipitation of N-Rho-PE/PC/PS (1:49:50) vesicles with
L2GP1 or G274^C288. Vesicles (5 WM) were incubated with in-
creasing concentrations of L2GP1 (a, b) or peptide (O, R) for
1 h at 20‡C. After centrifugation, the fraction of lipid precipi-
tated was determined by £uorescence. Tris^EDTA (closed sym-
bols), Tris^EDTA/150 mM NaCl (open symbols).
Fig. 2. L2GP1-Dependent E/M changes in PS vesicles. Vesicles
containing Pyr-PC/PC/PS (10:40:50) were incubated with in-
creasing concentrations of L2GP1 (a, b) or G274^C288 (O, R)
for 5 min at 20‡C. Vesicles were incubated in Tris^EDTA
(closed symbols), Tris^EDTA/150 mM NaCl (open symbols).
Vesicles containing only Pyr-PC/PC (10:90) were used as nega-
tive controls (W).
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vesicles, and probe dilution was monitored as a func-
tion of E/M. In contrast to the dramatic V65% de-
crease in E/M observed upon the addition of Ca2,
the addition of L2GP1 to PS-containing vesicles re-
sulted in only a V18% decrease in E/M (Fig. 4A). In
addition, L2GP1 did not promote RET between
N-NBD-PE and N-Rho-PE labeled membranes
(Fig. 4B). These independent results indicate that
L2GP1 did not induce vesicle fusion and raise the
possibility that precipitation might be due to vesicle
cross-linking. Light-scattering experiments indicated
that particle size was dependent on both the concen-
Fig. 4. L2GP1 does not induce vesicle^vesicle fusion. (A) Pyr-PC/PC/PS (10:40:50) vesicles (4 WM) were mixed with unlabeled vesicles
(20 WM) and incubated with 300 nM L2GP1 (a), 300 nM ovalbumin (P) or 5 mM Ca2 (E). (B) RET between N-NBD-PE/PC/PS
(1:49:50) and N-Rho-PE/PC/PS (2:48:50) vesicles. Vesicles (5 WM of each population) were mixed and emission spectra (Vex 450 nm)
were recorded before (E), and after the addition of 300 nM L2GP1 (a) or 5 mM Ca2 (O).
Fig. 3. DPH polarization of PS vesicles. (A) Vesicles (4 WM) of the indicated compositions were labeled with DPH (1 WM) and incu-
bated with L2GP1 in Tris^EDTA. (E) 0 mol% PS; (O), 20 mol% PS; (W), 50 mol% PS; (a), 70 mol% PS. (B) The e¡ect of ionic
strength on P was determined with PC/PS (50:50) vesicles. Vesicles incubated with L2GP1 in the absence (b) and presence of 150 mM
NaCl (a). Vesicles incubated with ovalbumin (P).
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tration of L2GP1 and the fraction of PS in the mem-
brane (Fig. 5). Although particle sizes were in£u-
enced by salt (M2/M1 salt V2.4; M2/M1 no salt
3.2), precipitation occurred only in the absence of
salt (see Fig. 1). These data suggest that L2GP1 did
not induce extensive vesicle^vesicle cross-linking. The
addition of L2GP1 antibodies (20 Wg/ml), on the
other hand, aggregated the vesicles and resulted in
M2/M1s 20.
3.4. Resonance energy transfer between L2GP1 and
target membranes
While the ¢fth domain of L2GP1 is principally
responsible for its binding speci¢city [12,14], it has
recently been suggested that domains I through IV
adsorb parallel to the bilayer surface in low ionic
strength bu¡ers [17]. To determine if binding through
these domains are concurrent or sequential, the asso-
ciation of domain II/III by RET between FITC^mal-
eimide-labeled L2GP1 and N-Rho-PE containing
vesicles was monitored in hypotonic and isotonic
bu¡ers. Sequential emission scans taken at 12 s in-
tervals showed a rapid decrease in £uorescent inten-
sity at 520 nm for vesicles in both the absence and
presence of 150 mM NaCl. However, in contrast to
the progressive decrease observed in low salt solu-
tions, no decrease beyond the second scan was ob-
served in the presence of 150 mM NaCl. To analyze
the kinetics of these processes in greater detail, £uo-
rescence intensities were monitored in real-time at
520 nM and RET e⁄ciencies were calculated. Fig.
Table 1
Kinetics of RETa
Fast component (%/s) Slow component (%/s)
PC/PS 10 mM Tris 17.4 0.17
PC/PS 150 mM salt 17.3 6 0.0005
PC vesicles 10 mM Tris ^ 6 0.0005
aResonance energy transfer e⁄ciency was calculated from the data presented in Fig. 6D. The initial rates were calculated from the lin-
ear components of each curve.
Fig. 5. Relative molecular mass of L2GP1/vesicle complexes. M2/M1 was calculated for vesicles incubated for 10 min with increasing
concentrations of L2GP1 at di¡erent PC/PS ratios in the absence (A) and presence (B) of 150 mM NaCl by monitoring 90‡ light scat-
tering at 320 nm. 0 mol% (E, F), 10 mol% (P, S), 20 mol% (O, R), 30 mol% (+), 40 mol% (W, 8), and 50 mol% PS (a, b). Inset:
M2/M1 for vesicles containing increasing fractions of PS incubated with L2GP1 (600 nM) in the absence (open symbols) and presence
of 150 mM NaCl (closed symbols).
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6D shows that the initial rates of RET were similar
in both bu¡er systems. However, while the reaction
appeared to be complete within several seconds in
isotonic bu¡er, the reaction progressed albeit at a
lower rate in low salt (Table 1). Analysis of the pri-
mary domain V interaction monitored by tryptophan
£uorescence [17] showed that the emission peak shift
was complete in 6 4 s and was not in£uenced by the
ionic strength of the bu¡er (Fig. 7). These data sug-
gest that the rapid increase in RET and tryptophan
wavelength shift report on a primary interaction be-
tween L2GP1 and the target vesicle. In low ionic
strength bu¡er, RET continues to increase at a
much slower rate suggesting that a secondary inter-
action occurs at a site distinct from domain V. Since
the initial rates in both systems were identical, we
assume that the initial L2GP1 interactions are the
same and that the secondary interaction is sequential
to the primary. Taken together, these data suggest
that the binding of L2GP1 to membranes can be
separated into two distinct interactions: (1) primary
binding to domain V that is insensitive to ionic
strength, and (2) secondary binding involving do-
mains II/III that are sensitive to ionic strength. It
should be noted that while these binding activities
are distinct, both are likely PS-dependent since di¡er-
entially labeled PC/PS and PC vesicles did not co-
precipitate (Table 2).
Fig. 6. Extrinsic (£uorescein-labeled) £uorescence of L2GP1 incubated with PS vesicles. The change in the £uorescence intensity of
L2GP1 (15 nM) was monitored upon the addition of vesicles (40 WM). Panels A^C show sequential emission scans (Vex 450 nm) at
V12 s intervals for vesicles containing 2% N-Rho-PE. (A) PC/PS vesicles in Tris^EDTA; (B) PC/PS vesicles in Tris^EDTA/150 mM
NaCl; (C) PC vesicles in Tris^EDTA. To calculate the rate of L2GP1 association with the target vesicles, the intensity of FITC £uo-
rescence was monitored at 520 nm (Vex 450 nm) before and upon the addition of vesicles (arrow) in real-time (intensity was recorded
at 0.1 s intervals). The calculated RET is shown in panel D. RET was calculated using 13I2/I1 where I1 and I2 are the intensities of
FITC-L2GP1 in the absence and presence of acceptor vesicles, respectively.
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4. Discussion
Several studies have shown that binding of L2GP1
with target membranes bearing negatively-charged
lipids induce agglutination and precipitation [19,20].
While this might be due to di¡erences in the dissoci-
ation constants at low and high ionic strength
(V1039 and V1036 M, respectively [20,36]), the
mechanism responsible for the precipitation is not
known. Interestingly, Hagihara et al. [12] have
shown that in addition to the relatively high a⁄nity
binding of domain V to lipids, domain I also exhibits
lipid binding properties, albeit at relatively low a⁄n-
ities. These data raise the possibility that precipita-
tion of membranes in low ionic strength bu¡ers is the
result of multiple protein/membrane interactions [17].
Conceivably, these interactions could occur within
the same membrane through global membrane alter-
ations, or between adjacent membranes by cross-
linking.
The e¡ect of L2GP1 on target membranes was
monitored in sonicated vesicles containing pyrene-la-
beled PC and DPH. The ability of L2GP1 to alter the
£uidity of membranes can be seen from the data
presented in Figs. 2 and 3 where the addition of
the protein decreased E/M with a concomitant in-
crease in membrane polarization. These data suggest
that since E/M depends on the rate of intermolecular
collisions between pyrene moieties [25,26], the en-
hancement of membrane rigidity is responsible for
the decreased collisional frequency. Since L2GP1
binds multiple lipid residues [12], it is possible that
it could induce intervesicular aggregation thereby
juxtaposing the membranes that generate conditions
conducive to vesicle^vesicle fusion. Pyrene-labeled
probe dilution and RET experiments ruled out the
possibility of vesicle^vesicle fusion (Fig. 4). More-
over, 90‡ light-scattering experiments indicated
that large vesicle aggregates were not formed (M2/
M16 3; Fig. 5).
In contrast to the data obtained in low ionic
strength bu¡ers, the inclusion of 150 mM NaCl de-
creased pyrene E/M ratios by V50% but diminished
the alterations in membrane polarization. Collec-
tively, these data raise the possibility that the assays
report on di¡erent binding activities. Conceivably,
the primary interaction is seen as a reduction in pyr-
ene E/M ratios, followed by a secondary interaction
that is seen as a cumulative decrease in E/M as well
as changes in membrane polarization. These data
suggest that a L2GP1 lipid-binding domain, distinct
from the primary domain V site, is critical to mem-
brane precipitation. Indeed, vesicles incubated with
G274^C288, a domain V lipid binding sequence, pro-
duced E/M changes similar to L2GP1 in the presence
of 150 mM NaCl (Fig. 2) and did not induce precip-
itation (Fig. 1).
To distinguish between primary and secondary site
Fig. 7. Intrinsic (tryptophan) £uorescence emission peaks of
L2GP1 incubated with PS vesicles. L2GP1 was incubated with
PC (squares) and PC/PS (circles) vesicles in the presence (closed
symbols) and absence (open symbols) of 150 mM NaCl for
5 min at 20‡C. Tryptophan £uorescence emission spectra were
monitored from 320^360 nm (Vex 280 nm).
Table 2
Di¡erential precipitation of PC and PC/PS vesicles by L2GP1a
Fraction of lipid precipitated
NBD-(PC/PS)+
Rho-(PC/PS)
NBD-(PC/PS)+
Rho-(PC)
NBD 0.92 0.84
Rho 0.94 0.02
aVesicles (10 WM) composed of PC/PS or PC containing N-
NBD-PE or N-Rho-PE (V1 mol%) were incubated with L2GP1
(600 nM) for 10 min at 20‡C. Aliquots were removed before
and after centrifugation at 15 000Ug for 15 min. The samples
were diluted in 1% Triton X-100, and NBD and Rho £uores-
cence was measured.
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binding, the sequential deposition of both the C-
(domain V) and N- (domain I) terminal regions of
the protein were monitored by intrinsic tryptophan
wavelength shifts [17] and RET between £uorescein-
labeled L2GP1 and rhodamine-labeled vesicles, re-
spectively. Figs. 6 and 7 show an increase in RET
between the protein and the target membrane and a
V10 nm blue shift in the tryptophan emission spec-
tra of L2GP1 in both hypotonic and isotonic bu¡ers.
Although further time-dependent alterations in tryp-
tophan £uorescence were not observed, RET contin-
ued to develop in low ionic strength bu¡er (Fig. 6).
Since the £uorescent probe is localized to domains II/
III, the progressive increase in RET most likely re-
£ects ionic strength-dependent adsorption of the N-
terminus on the membrane surface. Although these
results cannot unequivocally rule out the possibility
of intervesicle cross-links, the e⁄ciency of energy
transfer (V50%) would seem to favor minimal dis-
tances between £uorophores, arguing towards an in-
travesicle interaction. This conclusion is further sup-
ported by the light-scattering experiments (Fig. 5).
These data support the hypothesis that L2GP1 can
adopt at least two conformations upon binding to
PS-containing targets [17,18]. In low ionic strength
bu¡ers, the protein assumes a conformation in which
both the C- and N-termini are oriented along the
plane of the lipid bilayer, facilitating binding to the
membrane at two distinct sites. In isotonic bu¡ers,
however, only the C-terminus is bound while the N-
terminus remains in solution because of its low a⁄n-
ity to lipids. Alternatively, the primary domain V
interaction could induce a single conformational
change independent of ionic strength that only
makes binding to the newly accessible domain II/III
binding site possible. Taken together, these data in-
dicate that multivalent interactions within the same
target membrane occur in hypotonic bu¡ers that in-
duce membrane alterations of su⁄cient magnitude to
result in precipitation. In isotonic bu¡er, however,
the conformational change would still occur, but as-
sociation of the N-terminus to the target membrane
would be precluded. Such a situation would provide
a conformationally altered N-terminus available for
other functionally relevant interactions.
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